Benzinga | May 7, 2021 07:38AM EDT

Meridian Bioscience Q2 Adj. EPS $0.56 Beats $0.48 Estimate, Sales $85.30M Beat $84.48M Estimate

Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.48 by 16.67 percent. This is a 143.48 percent increase over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $85.30 million which beat the analyst consensus estimate of $84.48 million by 0.97 percent. This is a 48.88 percent increase over sales of $57.30 million the same period last year.